Literature DB >> 34364685

Synthetic gene circuits as tools for drug discovery.

Adam M Beitz1, Conrad G Oakes2, Kate E Galloway3.   

Abstract

Within mammalian systems, there exists enormous opportunity to use synthetic gene circuits to enhance phenotype-based drug discovery, to map the molecular origins of disease, and to validate therapeutics in complex cellular systems. While drug discovery has relied on marker staining and high-content imaging in cell-based assays, synthetic gene circuits expand the potential for precision and speed. Here we present a vision of how circuits can improve the speed and accuracy of drug discovery by enhancing the efficiency of hit triage, capturing disease-relevant dynamics in cell-based assays, and simplifying validation and readouts from organoids and microphysiological systems (MPS). By tracking events and cellular states across multiple length and time scales, circuits will transform how we decipher the causal link between molecular events and phenotypes to improve the selectivity and sensitivity of cell-based assays.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  disease modeling; drug discovery; gene circuit; screening; synthetic biology

Mesh:

Year:  2021        PMID: 34364685     DOI: 10.1016/j.tibtech.2021.06.007

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  1 in total

1.  Overstatements and Understatements in the Debate on Synthetic Biology, Bioterrorism and Ethics.

Authors:  Anders Melin
Journal:  Front Bioeng Biotechnol       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.